文献速递肝病

使用剪切波弹性成像无创评估门静脉高压:对191例肝硬化患者联合肝脾硬度的两种算法的分析

Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis.
PubMed 文献 · Aliment Pharmacol Ther · 2018-01-11

本研究在外部队列中验证两种基于二维剪切波弹性成像序贯测量肝脾硬度以评估临床显著门静脉高压(HVPG≥10 mmHg)的算法。纳入191例稳定期肝硬化患者,第一种算法排除HVPG≥10 mmHg的敏感度95%、阴性预测值63%;第二种算法纳入HVPG≥10 mmHg的特异度52%、阳性预测值83%。结论认为两种算法诊断准确性可接受,但不足以替代HVPG测量或作为临床决策依据。

要点

  • 第一种算法(肝硬度<16.0 kPa,再脾硬度<26.6 kPa)排除HVPG≥10 mmHg的敏感度95%、阴性预测值63%。
  • 第二种算法(肝硬度>38.0 kPa,或肝硬度≤38.0 kPa但脾硬度>27.9 kPa)纳入HVPG≥10 mmHg的特异度52%、阳性预测值83%。
  • 限定于74例无失代偿史或65例肝硬度测量高度可靠的患者分析未改善结果。

核心结论

  • 在该人群中,基于二维剪切波弹性成像序贯测量肝脾硬度的无创算法诊断准确性可接受,但不足以替代HVPG测量或作为临床决策依据。

研究设计与样本

  • 外部验证研究,纳入191例稳定期肝硬化患者(Child-Pugh A级39%、B级29%、C级31%),在HVPG测量时使用二维剪切波弹性成像测量肝脾硬度。

主要发现

  • 第一种算法(肝硬度<16.0 kPa,再脾硬度<26.6 kPa)用于排除HVPG≥10 mmHg,敏感度95%、阴性预测值63%。
  • 第二种算法(肝硬度>38.0 kPa,或肝硬度≤38.0 kPa但脾硬度>27.9 kPa)用于纳入HVPG≥10 mmHg,特异度52%、阳性预测值83%。
  • 限定于74例无失代偿史或65例肝硬度测量高度可靠的患者分析未改善结果。

关键数值与推荐

  • 第一种算法:肝硬度<16.0 kPa,再脾硬度<26.6 kPa,用于排除HVPG≥10 mmHg。
  • 第二种算法:肝硬度>38.0 kPa,或肝硬度≤38.0 kPa但脾硬度>27.9 kPa,用于纳入HVPG≥10 mmHg。

临床怎么用

  • 原文结论认为两种算法诊断准确性可接受但不足以替代HVPG测量或作为临床决策依据,原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two algorithms based on sequential measurements of liver and spleen stiffness using two-dimensional shearwave elastography (2D-SWE) have been recently proposed to estimate clinically significant portal hypertension (hepatic venous pressure gradient [HVPG] ≥10 mm Hg) in patients with cirrhosis, with excellent diagnostic accuracy. AIM: To validate externally these algorithms in a large cohort of patients with cirrhosis. METHODS: One hundred and ninety-one patients with stable cirrhosis (Child-Pugh class A 39%, B 29% and C 31%) who underwent liver and spleen stiffness measurements using 2D-SWE at the time of HVPG measurement were included. Diagnostic accuracy of the 2 algorithms was assessed by calculating sensitivity, specificity, positive and negative predictive values. RESULTS: The first algorithm, using liver stiffness <16.0 kilopascals (kPa) and then spleen stiffness <26.6 kPa, was used to rule-out HVPG ≥10 mm Hg. In our population, its sensitivity and negative predictive value were 95% and 63% respectively. The second algorithm, using liver stiffness >38.0 kPa, or liver stiffness ≤38.0 kPa but spleen stiffness >27.9 kPa, was used to rule-in HVPG ≥10 mm Hg. In our population, its specificity and positive predictive value were 52% and 83% respectively. Restricting the analyses to the 74 patients without any history of decompensation of cirrhosis or to the 65 patients with highly reliable liver stiffness measurement did not improve the results. CONCLUSION: In our population, diagnostic accuracies of non-invasive algorithms based on sequential measurements of liver and spleen stiffness using 2D-SWE were acceptable, but not good enough to replace HVPG measurement or to base clinical decisions.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Elkrief L, Ronot M, Andrade F, et al. Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther. 2018. PMID: 29322599. doi:10.1111/apt.14488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。